ÃÑ 505ÆäÀÌÁö
493ÆäÀÌÁö º»¹®½ÃÀÛ

ȯ±â°ü·ùºñ
ȯ±â°ü·ùºñ ventilationperfusionratio
ȯÀÚÁ¤º¸ signalment
ȯ±â°ü·ùºñºÒ±Õµî ventilationperfusioninequality
ȯÀÚÈ®ÀÎ patientidentification
ȯ±â±¸ ventilatingopening
ȯÃß atlas
ȯ±â±â ventilator
ȯġ diphyodont
ȯ±â´É·Â ventilatorycapacity
ȯÇüµ¿¹° annelid
ȯ±â´ç·® ventilationequivalent
ȯÇüµ¿¹° Annelida
ȯ±â·® ventilatingvolume,ventilation
ȯÇüµ¿¹°Áõ annelidiasis
ȯ±âºÎÀü ventilatoryfailure
È° arc,arch,bow
ȯ±âºÎÁ· ventilatoryinsufficiency
È°²¿¸® sabertail
ȯ±â¿¹ºñ·® breathingreserve
È°²Ãµ¿¸Æ arcuateartery
ȯ±â¿¹ºñ·Â ventilationreserve
È°²Ã¼± arcuateline
ȯ±â¿¹ºñÀ² breathingreserveratio
È°²ÃÃþ zonaarcuata
ȯ±âÀ² ventilationrate
È°²ÃÄáÆÏ renarcuatus
ȯ±âÀåÄ¡ ventilationfacility,ventilationsystem
È°µ¿ action,activity
ȯ±âÀú»ê¼ÒÁõ tidalhypoxia
È°µ¿°áÇÙ activetuberculosis
ȯ±âÇ÷·ùºñÀ² ventilationbloodflowratio
È°µ¿³óµµ activeconcentration
ȯ»ê¿·® reducedheat
È°µ¿¶³¸² actiontremor
ȯ»ó phantom
È°µ¿Àå·Â activetension
ȯ»ó¹é¼± tineacircinata
È°µ¿Àü·ù actioncurrent
ȯ¾à pellet
È°µ¿ÀüÀ§ actionpotential
ȯ¿ Cyclorrhapha
È°·Â vigor,vitalforce
ȯ¿ø deoxidation,reduction
È°·Â¼³ vitalism
ȯ¿ø´ç reducingsugar
È°·Â¼Ò½Ç devitalization
ȯ¿ø´ç·® reducingequivalent
È°·ÂÀúÇÏ hypodynamia
ȯ¿ø¼º reducibility,reducible
È°·ÂÀúÇÏ°¾ÆÁöÁõÈıº fadingpuppysyndrome
ȯ¿ø½Ã¾à reducingagent
È°·ÂÀúÇϵÅÁöÁõÈıº fadingpigsyndrome
ȯ¿ø½ÃÇè reductiontest
È°·ÂÀúÇϸ»ÁõÈıº fadinghorsesyndrome
ȯ¿øÀÎÀÚ reducingfactor
È°·Â¡ÈÄ vitalsign
ȯ¿øÀüÀ§ reductionpotential
È°·Â¡Èıâ·Ï vitalrecord
ȯ¿øÁ¦ reducer,reducingagent,reductant
È°·Âģȼº vitalaffinity
ȯ¿øÅ»Àå reduciblehernia
È°¸ð¾ç°Á÷ opisthotonos
ȯ¿øÇöóºó´Ü¹éÁú reducedflavoprotein
È°¹ØÆ´»õ subarcuatehiatus
ȯ¿øÇ÷»ö¼Ò reducedhemoglobin
È°»ê¼º activeacidity
È°¼® talc,talcum
ȯ¿øÇü´ÏÄÚƾ¾Æ¸¶À̵å¾Æµ¥´Ñ´ÙÀÌ´ºÅ¬·¹¿ÀŸÀ̵å
nicotinamideadeninedinucleotidereduced
È°¼®°¡·ç talcumpowder
form
È°¼®Áõ talcosis
È°¼º active,activity
ȯ¿øÇü´ÏÄÚƾ¾Æ¸¶À̵å¾Æµ¥´Ñ´ÙÀÌ´ºÅ¬·¹¿ÀŸÀ̵åÀλê
nicotinamideadeninedinucleotidephosphate
È°¼º°ñ¼ö activemarrow
reducedform
È°¼ºµµ activity
ȯ¿øÈ¿¼Ò reducingenzyme,reductase
È°¼º¸Å°³Ã¼ animatevehicle
ȯÀÚ patient,subject
È°¼º¹°Áú activematerial
ȯÀÚ´ëÁ¶±º¿¬±¸ casecontrolstudy
È°¼º¹éÅä activatedclay
ȯÀÚ·Â patienthistory
È°¼ººÎÀ§ activesite
ȯÀڹ߻ýÁöµµ spotmap
È°¼º»ê¼Ò activeoxygen
ȯÀڹ߻ýÁöµµÀÛ¼º spotmapping
È°¼º¼¼Æ÷ activatedcell
1036
¦
ȯ±â°ü·ùºñ ventilationperfusionratio
ȯÀÚÁ¤º¸ signalment
ȯ±â°ü·ùºñºÒ±Õµî ventilationperfusioninequality
ȯÀÚÈ®ÀÎ patientidentification
ȯ±â±¸ ventilatingopening
ȯÃß atlas
ȯ±â±â ventilator
ȯġ diphyodont
ȯ±â´É·Â ventilatorycapacity
ȯÇüµ¿¹° annelid
ȯ±â´ç·® ventilationequivalent
ȯÇüµ¿¹° Annelida
ȯ±â·® ventilatingvolume,ventilation
ȯÇüµ¿¹°Áõ annelidiasis
ȯ±âºÎÀü ventilatoryfailure
È° arc,arch,bow
ȯ±âºÎÁ· ventilatoryinsufficiency
È°²¿¸® sabertail
ȯ±â¿¹ºñ·® breathingreserve
È°²Ãµ¿¸Æ arcuateartery
ȯ±â¿¹ºñ·Â ventilationreserve
È°²Ã¼± arcuateline
ȯ±â¿¹ºñÀ² breathingreserveratio
È°²ÃÃþ zonaarcuata
ȯ±âÀ² ventilationrate
È°²ÃÄáÆÏ renarcuatus
ȯ±âÀåÄ¡ ventilationfacility,ventilationsystem
È°µ¿ action,activity
ȯ±âÀú»ê¼ÒÁõ tidalhypoxia
È°µ¿°áÇÙ activetuberculosis
ȯ±âÇ÷·ùºñÀ² ventilationbloodflowratio
È°µ¿³óµµ activeconcentration
ȯ»ê¿·® reducedheat
È°µ¿¶³¸² actiontremor
ȯ»ó phantom
È°µ¿Àå·Â activetension
ȯ»ó¹é¼± tineacircinata
È°µ¿Àü·ù actioncurrent
ȯ¾à pellet
È°µ¿ÀüÀ§ actionpotential
ȯ¿ Cyclorrhapha
È°·Â vigor,vitalforce
ȯ¿ø deoxidation,reduction
È°·Â¼³ vitalism
ȯ¿ø´ç reducingsugar
È°·Â¼Ò½Ç devitalization
ȯ¿ø´ç·® reducingequivalent
È°·ÂÀúÇÏ hypodynamia
ȯ¿ø¼º reducibility,reducible
È°·ÂÀúÇÏ°¾ÆÁöÁõÈıº fadingpuppysyndrome
ȯ¿ø½Ã¾à reducingagent
È°·ÂÀúÇϵÅÁöÁõÈıº fadingpigsyndrome
ȯ¿ø½ÃÇè reductiontest
È°·ÂÀúÇϸ»ÁõÈıº fadinghorsesyndrome
ȯ¿øÀÎÀÚ reducingfactor
È°·Â¡ÈÄ vitalsign
ȯ¿øÀüÀ§ reductionpotential
È°·Â¡Èıâ·Ï vitalrecord
ȯ¿øÁ¦ reducer,reducingagent,reductant
È°·Âģȼº vitalaffinity
ȯ¿øÅ»Àå reduciblehernia
È°¸ð¾ç°Á÷ opisthotonos
ȯ¿øÇöóºó´Ü¹éÁú reducedflavoprotein
È°¹ØÆ´»õ subarcuatehiatus
ȯ¿øÇ÷»ö¼Ò reducedhemoglobin
È°»ê¼º activeacidity
È°¼® talc,talcum
ȯ¿øÇü´ÏÄÚƾ¾Æ¸¶À̵å¾Æµ¥´Ñ´ÙÀÌ´ºÅ¬·¹¿ÀŸÀ̵å
nicotinamideadeninedinucleotidereduced
È°¼®°¡·ç talcumpowder
form
È°¼®Áõ talcosis
È°¼º active,activity
ȯ¿øÇü´ÏÄÚƾ¾Æ¸¶À̵å¾Æµ¥´Ñ´ÙÀÌ´ºÅ¬·¹¿ÀŸÀ̵åÀλê
nicotinamideadeninedinucleotidephosphate
È°¼º°ñ¼ö activemarrow
reducedform
È°¼ºµµ activity
ȯ¿øÈ¿¼Ò reducingenzyme,reductase
È°¼º¸Å°³Ã¼ animatevehicle
ȯÀÚ patient,subject
È°¼º¹°Áú activematerial
ȯÀÚ´ëÁ¶±º¿¬±¸ casecontrolstudy
È°¼º¹éÅä activatedclay
ȯÀÚ·Â patienthistory
È°¼ººÎÀ§ activesite
ȯÀڹ߻ýÁöµµ spotmap
È°¼º»ê¼Ò activeoxygen
ȯÀڹ߻ýÁöµµÀÛ¼º spotmapping
È°¼º¼¼Æ÷ activatedcell
1036
¦
493ÆäÀÌÁö º»¹®³¡
¸Þ´º
ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.